Mounjaro vs Wegovy: Which Online Prescription Suits You?
Compare Mounjaro and Wegovy Online Prescription Process
When you compare Mounjaro and Wegovy through EverydayMeds, both treatments follow the same streamlined online prescription process designed to remove barriers to access. Our 3-minute clinical assessment covers medical history, current medications, BMI calculations, and contraindications for both semaglutide (Wegovy) and tirzepatide (Mounjaro). Licensed UK prescribers review every application within 3 working days as standard, or 24 hours with our express service. The assessment determines which treatment may be most suitable based on your individual medical profile and circumstances.
Both prescription-only medicines require the same clinical criteria: BMI ≥30, or BMI ≥27 with weight-related comorbidities, alongside commitment to reduced-calorie diet and increased physical activity. Our prescribers can help you compare Mounjaro and Wegovy options during the assessment process, explaining how each mechanism works and which might align better with your treatment goals. No GP appointment or referral is required, making this the most efficient way to access either medication in the UK.
Wegovy Pricing and Mounjaro Cost Comparison
When you compare Mounjaro and Wegovy pricing, Wegovy starts at £79.99 for the initial 0.25mg pen with discount code FIRST40 applied at checkout. The dose escalation follows: 0.5mg £94.99, 1mg £99.99, 1.7mg £139.99, and maintenance 2.4mg £209.99. Our bundle options provide convenience for planning your treatment journey, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99. Returning customers benefit from code DOSE25 at checkout.
Whilst Mounjaro follows a different pricing structure due to its dual-agonist formulation, both treatments represent significant investment in long-term weight management. The value comparison extends beyond initial cost to include storage convenience, dosing frequency, and clinical trial outcomes. Both medications are once-weekly injections delivered via pre-filled pens, with next-day cold-chain delivery ensuring medication integrity. Our GPhC-registered pharmacy (#9012878) maintains strict temperature controls throughout the supply chain for both treatments.
Clinical Evidence: Mounjaro vs Wegovy Effectiveness
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021), compared to 2.4% with placebo. The STEP programme demonstrated consistent results across different populations, with STEP 2 showing clinically studied weight loss in patients with type 2 diabetes. When you compare Mounjaro and Wegovy trial data, both medications showed significant efficacy, though different trial designs and populations make direct percentage comparisons inappropriate.
The SELECT cardiovascular outcomes trial demonstrated that Wegovy may reduce major cardiovascular events by 20% in adults with established cardiovascular disease. Both treatments work through incretin hormone pathways, though Mounjaro's dual GIP and GLP-1 mechanism differs from Wegovy's GLP-1-only approach. Clinical evidence supports both options as effective prescription weight management tools when used alongside lifestyle modifications.
How Wegovy Works Compared to Mounjaro Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1, which regulates appetite and glucose metabolism. This mechanism reduces appetite by acting on brain appetite centres, promotes feeling of fullness after smaller meals, and may reduce food cravings throughout the day. Mounjaro uses tirzepatide, which targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors simultaneously, creating a dual-agonist effect. Both medications slow gastric emptying, helping maintain satiety for longer periods after eating. When you compare Mounjaro and Wegovy mechanisms, both ultimately achieve appetite suppression and improved glycemic control, but through slightly different receptor pathways that may suit different metabolic profiles.
Online Ordering Process for Both Treatments
The EverydayMeds online prescription process makes it simple to compare Mounjaro and Wegovy options from the comfort of your home. Complete the 3-minute clinical assessment covering medical history, current medications, weight management goals, and lifestyle factors relevant to both treatments. Licensed UK prescribers review your application, considering which medication may be most appropriate based on your individual profile and preferences. Once approved, both treatments are dispatched via next-day cold-chain delivery using specialised temperature-controlled packaging to maintain medication integrity. The entire process typically takes 3 working days from assessment to delivery, with express 24-hour options available.
Storage and Practical Considerations
When you compare Mounjaro and Wegovy storage requirements, Wegovy offers a significant practical advantage with 6 weeks room temperature stability once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature tolerance makes it more suitable for travel or flexible lifestyle situations. Both use pre-filled FlexTouch injection pens with once-weekly dosing schedules. Wegovy follows a mandatory dose escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance from week 17. Both treatments require consistent weekly injection timing and cannot skip dose escalation steps.
Choosing Between Mounjaro and Wegovy Online Prescription Options
The decision to compare Mounjaro and Wegovy through online prescription services depends on several factors including medical history, previous treatment responses, and lifestyle requirements. Wegovy's single-agonist GLP-1 mechanism may be preferable for patients who respond well to this pathway, whilst Mounjaro's dual-agonist approach might benefit those requiring broader metabolic effects. Online prescription services eliminate traditional barriers like GP waiting times, allowing faster access to both treatments through comprehensive remote clinical assessment.
Both medications are subject to MHRA additional monitoring and require ongoing medical supervision throughout treatment. Our licensed prescribers can guide your choice during the assessment process, explaining how each medication's profile aligns with your individual circumstances. The convenience of comparing Mounjaro and Wegovy options online, combined with next-day delivery and ongoing clinical support, makes EverydayMeds an efficient pathway to either treatment.
Start Your Wegovy or Mounjaro Journey Today
Both Wegovy and Mounjaro are available from EverydayMeds through our streamlined online prescription service, allowing you to compare options and access treatment without traditional healthcare delays. Use discount code FIRST40 for new customers or DOSE25 for returning customers, applied automatically at checkout to reach our competitive pricing. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance and medication authenticity for both treatments. Licensed UK prescribers are available to discuss which option may be most suitable during your clinical assessment. Visit https://everydaymeds.co.uk/collections/wegovy to begin your 3-minute assessment and compare both treatment options with expert clinical guidance.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
